Unique ID issued by UMIN | UMIN000015761 |
---|---|
Receipt number | R000018341 |
Scientific Title | A Randomized, Double-blind, Placebo-controlled Study on the Anti-Obesity Effect of Food Containing Rosehip Extract |
Date of disclosure of the study information | 2014/11/27 |
Last modified on | 2019/03/05 16:49:50 |
A Randomized, Double-blind, Placebo-controlled Study on the Anti-Obesity Effect of Food Containing Rosehip Extract
The Anti-Obesity Effect of Food Containing Rosehip Extract
A Randomized, Double-blind, Placebo-controlled Study on the Anti-Obesity Effect of Food Containing Rosehip Extract
The Anti-Obesity Effect of Food Containing Rosehip Extract
Japan |
No (Subjects whose BMI are 25 to 30)
Not applicable | Adult |
Others
NO
To examine the anti-obesity effect of food containing rosehip extract on body fat
Efficacy
Abdominal fat area
Body fat percent
Weight
BMI
Blood pressure
Heart rate
Waist circumference
Hip circumference
Skinfold thickness
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Tablet containing 100mg of rosehip extract, 1 per serving per day for 12 weeks
Tablet not containing rosehip extract, 1 per serving per day for 12 weeks
20 | years-old | <= |
Not applicable |
Male and Female
(1)Adult subjects whose BMI are 25 to 30
(2)Subjects giving written informed consent
(1)Subjects who have allergic reaction to medicine.
(2)Subjects who smoke excessively and drink alcohol habitually, and whose eating habits are extremely irregular.
(3)Subjects who has liver dysfunction or renal dysfunction.
(4)Subjects who has history of surgery on gastrointestinal part such as gastrectomy, gastrointestinal suture, and intestinal resection.
(5)Subjects who donated 400 mL of blood within 12 weeks before starting of administration, or who donated 200 mL of blood within 4 weeks or donated blood component within 2 weeks.
(6)Midnight and irregular shift worker.
(7)Subjects who are during pregnancy, nursing, and who plan to become pregnant within six months.
(8)Subjects who are judged as unsuitable for the study by the investigator for other reason.
32
1st name | |
Middle name | |
Last name | Ikuo Fukuhara |
Fukuhara clinic
Medical office
3-1-15 Shimamatsuhigashimachi, Eniwashi, Hokkaido
0123-36-8029
i-feniwa@gray.plala.or.jp
1st name | |
Middle name | |
Last name | Akifumi Nagatomo |
Morishita Jintan Co.,Ltd.
Research and Development Division
Osaka Techno Center, 2-11-1, Tsudayamate, Hirakata, Osaka
072-800-1044
a-nagatomo@jintan.co.jp
Morishita Jintan Co.,Ltd.
Morishita Jintan Co.,Ltd.
Profit organization
NO
2014 | Year | 11 | Month | 27 | Day |
Published
https://doi.org/10.2147/DMSO.S78623
Completed
2011 | Year | 07 | Month | 04 | Day |
2011 | Year | 09 | Month | 15 | Day |
2014 | Year | 11 | Month | 26 | Day |
2019 | Year | 03 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018341
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |